Reviewing The Magic Recipe Stocks: #1-10
What are the best stocks in the Magic Recipe Spell?
There are a lot of stocks in there - 50 in total. Doing full reviews on all 50 would take a substantial amount of time, and by the time we were done, the list would be all different again!
So we're breaking them up into 10 at a time and doing a "Twitter" style, 160-character maximum review of each current Magic Recipe stock (140 was not enough)! In addition, I'll provide a quick "thumbs up", "thumbs down", or "neutral" OPINION of each stock's potential to outperform the market over the next 12-18 months, as well as a basic-as-possible description of the company's business.
You can find reviews of stocks #41-50 here, #31-40 here, #21-30 here, and finally #11-20 right here. Today, let's cover the final stocks #1-10. With no further ado...
 |
#10: Buckle (BKE) Company Description: Mall clothing retail Outlook: Neutral. "Tweet" Review: Classic no-moat business. BKE well-run, good ROIs, no debt, solid dividend. Rev growth seems to have flat-lined. Valuation play only, no long-term value here. |
 |
Company Description: Regional sports networks for several New York area teams. Outlook: Thumbs up. "Tweet" Review: Regional SNs a good biz with defensible moat and solid cash flows. Don't expect much top line growth though. Lower end of 52-wk range. |
 |
#8: Chicago Bridge & Iron (CBI) Company Description: Engineering and construction, mostly in energy. Outlook: Thumbs up. "Tweet" Review: Divestiture of nuclear assets limits liability, alleviates cash flow issues. Growing backlog. Miscast as oil casualty - most work in power, LNG. Good upside. |
 |
Company Description: Eggs. Outlook: Neutral. "Tweet" Review: Benefited greatly from higher poultry and egg prices. Pure commodity biz. Egg pricing going forward unpredictable. Well-run, mkt share over 20%. OK option. |
 |
#6: Apple (AAPL) Company Description: You don't know? Outlook: Thumbs up. "Tweet" Review: Awash in cash gives plenty of optionality to expand from iPhone. iPhone still dominates profit share. Lock-in ecosystem. Big potential mkts in TV, cars. |
 |
#5: Tessera (TSRA) Company Description: Imaging and semiconductor IP licensing. Outlook: Neutral. "Tweet" Review: IP licensing is very high margin and generates solid, if lumpy cash flow. TSRA debt-free, loads of cash. No real moat as patents expire, new tech takes over. |
 |
#4: HP Inc (HPQ) Company Description: The legacy "PC and printers" part of Hewlett-Packard. Outlook: Neutral. "Tweet" Review: Still generating cash flow @ low margin. Heavy competition, esp. from Asia, margins perpetually falling. Not a great biz at this point, but stock is very cheap. |
 |
#3: United Therapeutics (UTHR) Company Description: Bio-pharma specializing in PAH treatments. Outlook: Thumbs up. "Tweet" Review: Dominated PAH. Legacy drugs maturing, nearing patent end, new treatments should maintain revenue. Neuroblastoma and organs next leg. Some management turnover. |
 |
#2: Gilead (GILD) Company Description: Bio-pharma specializing in HIV and Hep C treatments. Outlook: Thumbs up. "Tweet" Review: Dominates enormous hep C field with nearly 90% share. Dominates HIV with over 70% share. Market worried about next leg, but plenty of cash flow to develop it. |
 |
#1: Five Prime Therapeutics (FPRX) Company Description: Clinical stage biotech, arthritis and cancer indications. Outlook: ???? "Tweet" Review: In true "Magic" form, a lottery ticket stock at #1. In screen from a one-time milestone payment. Long way to sustained profitability. Good luck. |
Comments
